Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafael Franco

Showing results (41-50 of 420) with videos related to

Pageof 42
Sort By:
Progress in Neurobiology|September 7, 2007
Aspects of the general biology of adenosine A2A signalingBertil B Fredholm, Yijuang Chern, Rafael Franco, et al.
Expert Opinion on Therapeutic Targets|October 27, 2022
The adenosine A<sub>2A</sub> receptor is a therapeutic target in neurological, heart and oncogenic diseasesRafael Franco, Alejandro Lillo, Gemma Navarro, et al.
Synapse (New York, N.Y.)|March 26, 2010
Cocaine self-administration markedly increases dopamine D2 receptor negative cooperativity for dopamine binding: A receptor dimer-based analysisRafael Franco, Philip Seeman, Carlos Barrera, et al.
Plos Computational Biology|March 25, 2026
Physical models of embryonic epithelial healingRafael Franco Almada, Nuno André Miguel Araújo, Pedro Patrício
Progress in Neurobiology|February 13, 2017
Potential of GPCRs to modulate MAPK and mTOR pathways in Alzheimer's diseaseRafael Franco, Eva Martínez-Pinilla, Gemma Navarro, et al.
Bio-Protocol|March 3, 2021
Identification of Heteroreceptors Complexes and Signal Transduction Events Using Bioluminescence Resonance Energy Transfer (BRET)Irene Reyes-Resina, Jasmina Jiménez, Gemma Navarro, et al.
Trends in Biochemical Sciences|September 28, 2015
Structures for G-Protein-Coupled Receptor Tetramers in Complex with G ProteinsArnau Cordomí, Gemma Navarro, María S Aymerich, et al.
Frontiers in Genetics|December 13, 2017
The Epigenetic Cytocrin Pathway to the Nucleus. Epigenetic Factors, Epigenetic Mediators, and Epigenetic Traits. A Biochemist PerspectiveGemma Navarro, Nuria Franco, Eva Martínez-Pinilla, et al.
CNS & Neurological Disorders Drug Targets|July 17, 2010
Prime time for G-protein-coupled receptor heteromers as therapeutic targets for CNS disorders: the dopamine D₁-D₃ receptor heteromerSergi Ferré, Carmen Lluis, José Luis Lanciego, et al.
International Journal of Environmental Research and Public Health|December 30, 2025
Risk Factors for Social Exclusion and Stigma in a Group of Non-Hospitalised Patients with COVID-19Georgina Becerril-Serna, Rafael Franco-Cendejas, Francisco Paz-Rodríguez
Pageof 42

Showing results (41-50 of 420) with videos related to

Sort By:
Pageof 42
Progress in Neurobiology|September 7, 2007
Aspects of the general biology of adenosine A2A signalingBertil B Fredholm, Yijuang Chern, Rafael Franco, et al.
Expert Opinion on Therapeutic Targets|October 27, 2022
The adenosine A<sub>2A</sub> receptor is a therapeutic target in neurological, heart and oncogenic diseasesRafael Franco, Alejandro Lillo, Gemma Navarro, et al.
Synapse (New York, N.Y.)|March 26, 2010
Cocaine self-administration markedly increases dopamine D2 receptor negative cooperativity for dopamine binding: A receptor dimer-based analysisRafael Franco, Philip Seeman, Carlos Barrera, et al.
Plos Computational Biology|March 25, 2026
Physical models of embryonic epithelial healingRafael Franco Almada, Nuno André Miguel Araújo, Pedro Patrício
Progress in Neurobiology|February 13, 2017
Potential of GPCRs to modulate MAPK and mTOR pathways in Alzheimer's diseaseRafael Franco, Eva Martínez-Pinilla, Gemma Navarro, et al.
Bio-Protocol|March 3, 2021
Identification of Heteroreceptors Complexes and Signal Transduction Events Using Bioluminescence Resonance Energy Transfer (BRET)Irene Reyes-Resina, Jasmina Jiménez, Gemma Navarro, et al.
Trends in Biochemical Sciences|September 28, 2015
Structures for G-Protein-Coupled Receptor Tetramers in Complex with G ProteinsArnau Cordomí, Gemma Navarro, María S Aymerich, et al.
Frontiers in Genetics|December 13, 2017
The Epigenetic Cytocrin Pathway to the Nucleus. Epigenetic Factors, Epigenetic Mediators, and Epigenetic Traits. A Biochemist PerspectiveGemma Navarro, Nuria Franco, Eva Martínez-Pinilla, et al.
CNS & Neurological Disorders Drug Targets|July 17, 2010
Prime time for G-protein-coupled receptor heteromers as therapeutic targets for CNS disorders: the dopamine D₁-D₃ receptor heteromerSergi Ferré, Carmen Lluis, José Luis Lanciego, et al.
International Journal of Environmental Research and Public Health|December 30, 2025
Risk Factors for Social Exclusion and Stigma in a Group of Non-Hospitalised Patients with COVID-19Georgina Becerril-Serna, Rafael Franco-Cendejas, Francisco Paz-Rodríguez
Pageof 42